FAQ

Relenza

Known as: Glaxo Wellcome Brand of Zanamivir, Zanamivir GlaxoSmithKline Brand, Zanamivir Biota Brand 
 

Topic mentions per year

Topic mentions per year

1998-2016
051019982016

Related topics

Related topics

1 relation

Broader (1)

Zanamivir

Related mentions per year

Related mentions per year

1957-2018
1960198020002020
Relenza
Zanamivir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
Two neuraminidase (NA) inhibitors, zanamivir (Relenza) and oseltamivir phosphate (Tamiflu), have been licensed for use for the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.
Two neuraminidase (NA) inhibitors, zanamivir (Relenza) and oseltamivir phosphate (Tamiflu), have been licensed for the treatment… (More)
Is this relevant?
2009
2009
Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
A molecular model of the swine influenza A/H1N1 type-I neuraminidase was built using the pathogenic avian H5N1 type-I… (More)
Is this relevant?
2009
2009
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
Along with influenza vaccines, the world is currently almost completely dependent on two licensed drugs for the treatment or… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Structural characterization of the 1918 influenza virus H1N1 neuraminidase.
Influenza virus neuraminidase (NA) plays a crucial role in facilitating the spread of newly synthesized virus in the host and is… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.
Oseltamivir (Tamiflu) and zanamivir (Relenza), two extensively used clinically effective anti-influenza drugs, are viral… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2002
2002
Drug under test: influenza – Relenza in daily practice
A total of 5–7 million cases of the disease, 4.5 million medical certificates, 25,000 admissions to hospital, 15,000 mortalities… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2000
2000
Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation.
In a single-center, randomized study, zanamivir (Relenza) concentrations in induced sputum samples and nasal washings of healthy… (More)
Is this relevant?
1999
1999
Zanamivir (Relenza )--a new treatment for influenza.
Deaths from influenza are recorded every year in the UK and flu epidemics raise concerns for the safety of the young, the elderly… (More)
Is this relevant?
1999
1999
Relenza
How does Relenza work? It blocks the action of the enzyme neuraminidase (also called sialidase) on the surface of types A and B… (More)
Is this relevant?